179
Views
49
CrossRef citations to date
0
Altmetric
Original Research

Enhancing siRNA-based cancer therapy using a new pH-responsive activatable cell-penetrating peptide-modified liposomal system

, , , , , , , , & show all
Pages 2385-2405 | Published online: 28 Mar 2017

References

  • ShiJKantoffPWWoosterRFarokhzadOCCancer nanomedicine: progress, challenges and opportunitiesNat Rev Cancer2017171203727834398
  • KanamalaMWilsonWRYangMPalmerBDWuZMechanisms and biomaterials in pH-responsive tumour targeted drug delivery: a reviewBiomaterials20168515216726871891
  • ZuckermanJEDavisMEClinical experiences with systemically administered siRNA-based therapeutics in cancerNat Rev Drug Discov2015141284385626567702
  • SinghYTomarSKhanSBridging small interfering RNA with giant therapeutic outcomes using nanometric liposomesJ Control Release2015220pt A36838726528900
  • XiaYTianJChenXEffect of surface properties on liposomal siRNA deliveryBiomaterials201679566826695117
  • JhaveriATorchilinVIntracellular delivery of nanocarriers and targeting to subcellular organellesExpert Opin Drug Deliv2016131497026358656
  • ZhangDWangJXuDCell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systemsJ Control Release201622913013926993425
  • TaiWGaoXFunctional peptides for siRNA deliveryAdv Drug Deliv Rev Epub2016813
  • JiangTOlsonESNguyenQTRoyMJenningsPATsienRYTumor imaging by means of proteolytic activation of cell-penetrating peptidesProc Natl Acad Sci U S A200410151178671787215601762
  • NguyenQTTsienRYFluorescence-guided surgery with live molecular navigation – a new cutting edgeNat Rev Cancer201313965366223924645
  • ShiNQGaoWXiangBQiXREnhancing cellular uptake of activable cell-penetrating peptide-doxorubicin conjugate by enzymatic cleavageInt J Nanomedicine201271613162122619516
  • XiangBDongDWShiNQPSA-responsive and PSMA-mediated multifunctional liposomes for targeted therapy of prostate cancerBiomaterials201334286976699123777916
  • GaoWXiangBMengTTLiuFQiXRChemotherapeutic drug delivery to cancer cells using a combination of folate targeting and tumor microenvironment-sensitive polypeptidesBiomaterials201334164137414923453200
  • GaoWMengTShiNZhuangHYangZQiXTargeting and microenvironment-responsive lipid nanocarrier for the enhancement of tumor cell recognition and therapeutic efficiencyAdv Healthc Mater20154574875925522298
  • HeHSunLYeJEnzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agentsJ Control Release2016240677626514292
  • ZhangBZhangYLiaoZUPA-sensitive ACPP-conjugated nanoparticles for multi-targeting therapy of brain gliomaBiomaterials2015369810925443789
  • DuJLaneLANieSStimuli-responsive nanoparticles for targeting the tumor microenvironmentJ Control Release201521920521426341694
  • JhaveriADeshpandePTorchilinVStimuli-sensitive nanopreparations for combination cancer therapyJ Control Release201419035237024818767
  • KarimiMGhasemiASahandi ZangabadPSmart micro/nanoparticles in stimulus-responsive drug/gene delivery systemsChem Soc Rev20164551457150126776487
  • SawantRMHurleyJPSalmasoS“SMART” drug delivery systems: double-targeted pH-responsive pharmaceutical nanocarriersBioconjug Chem200617494394916848401
  • KorenEApteAJaniATorchilinVPMultifunctional PEGylated 2C5-immunoliposomes containing pH-sensitive bonds and TAT peptide for enhanced tumor cell internalization and cytotoxicityJ Control Release2012160226427322182771
  • ApteAKorenEKoshkaryevATorchilinVPDoxorubicin in TAT peptide-modified multifunctional immunoliposomes demonstrates increased activity against both drug-sensitive and drug-resistant ovarian cancer modelsCancer Biol Ther2014151698024145298
  • DingYSunDWangGLAn efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug deliveryInt J Nanomedicine2015106199621426491292
  • HanLGuoYMaHAcid active receptor-specific peptide ligand for in vivo tumor-targeted deliverySmall20139213647365823649993
  • ZhangQGaoHHeQTaming cell penetrating peptides: never too old to teach old dogs new tricksMol Pharm20151293105311826237247
  • ZhangWSongJZhangBLiuLWangKWangRDesign of acid-activated cell penetrating peptide for delivery of active molecules into cancer cellsBioconjug Chem20112271410141521663318
  • ZhangYRong QiXGaoYWeiLMaitaniYNagaiTMechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effectJ Control Release2007117228129017196291
  • LeamonCPReddyJAVlahovIRKleindlPJVetzelMWestrickESynthesis and biological evaluation of EC140: a novel folate-targeted vinca alkaloid conjugateBioconjug Chem20061751226123216984132
  • DongDWXiangBGaoWYangZZLiJQQiXRpH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cellsBiomaterials201334204849485923541420
  • LiangDSSuHTLiuYJWangATQiXRTumor-specific penetrating peptides-functionalized hyaluronic acid-d-alpha-tocopheryl succinate based nanoparticles for multi-task delivery to invasive cancersBiomaterials201571112326310359
  • DerjaguinBVMullerVMToporovYPEffect of contact deformations on the adhesion of particlesJ Colloid Interface Sci1975532314326
  • ChristieRJAndersonDJGraingerDWComparison of hydrazone heterobifunctional cross-linking agents for reversible conjugation of thiol-containing chemistryBioconjug Chem201021101779178720695431
  • MaDXShiNQQiXRDistinct transduction modes of arginine-rich cell-penetrating peptides for cargo delivery into tumor cellsInt J Pharm20114191–220020821843610
  • KominARussellLMHristovaKASearsonPCPeptide-based strategies for enhanced cell uptake, transcellular transport, and circulation: mechanisms and challengesAdv Drug Deliv Rev Epub2016613
  • JeongEJChoiMLeeJRhimTLeeKYThe spacer arm length in cell-penetrating peptides influences chitosan/siRNA nanoparticle delivery for pulmonary inflammation treatmentNanoscale2015747200952010426568525
  • Oude BlenkeEEvan den DikkenbergJvan KolckBKrosAMastrobattistaECoiled coil interactions for the targeting of liposomes for nucleic acid deliveryNanoscale20168168955896527073992
  • ZaroJLFeiLShenWCRecombinant peptide constructs for targeted cell penetrating peptide-mediated deliveryJ Control Release2012158335736122326404
  • TsengYCMozumdarSHuangLLipid-based systemic delivery of siRNAAdv Drug Deliv Rev200961972173119328215
  • ShiNQQiXRXiangBZhangYA survey on “Trojan Horse” peptides: opportunities, issues and controlled entry to “Troy”J Control Release2014194537025151981
  • GilleronJQuerbesWZeigererAImage-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escapeNat Biotechnol201331763864623792630
  • ZhouJChauYDifferent oligoarginine modifications alter endocytic pathways and subcellular trafficking of polymeric nanoparticlesBiomater Sci20164101462147227532744
  • KhalilIAKogureKFutakiSHarashimaHHigh density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expressionJ Biol Chem200628163544355116326716
  • ZhangJLiuDZhangMThe cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cellsInt J Nanomedicine2016113677369027536106
  • DuJZSunTMSongWJWuJWangJA tumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug deliveryAngew Chem Int Ed Engl201049213621362620391548
  • DuJZDuXJMaoCQWangJTailor-made dual pH-sensitive polymer-doxorubicin nanoparticles for efficient anticancer drug deliveryJ Am Chem Soc201113344175601756321985458